Hypertension Circulatory System Hypertension
Conditions
Interventions
Current interventions as of 29/01/2020:
The research project takes place in three distinct but linked phases - each of which will be conducted at a different time sequentially and invo
Sponsors
Imperial College London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 29/01/2020: All patients attending a primary or secondary care service for the treatment of hypertension or taking statins that are willing to take part _____ Previous inclusion criteria: All patients attending a primary or secondary care service for the treatment of hypertension that are willing to take part
Exclusion criteria
Exclusion criteria: In the opinion of the investigator unsuitable or unable to adequately complete questionnaire e.g. due to inadequate level of English comprehension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured during the data collection session: 1. Urine test of medication adherence. A urine sample will be tested for anti-hypertension and statin metabolites to give a valid and reliable direct measure of medication adherence within the past 24hrs. 2. Self-reported medication adherence. Using 3 item Likert scale from Voils 2012 | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured during the data collection session: 1. Habit, measured using the Self Report Automaticity Index, a 4-item Likert scale from Gardner 2012 | — |
Countries
England, United Kingdom
Outcome results
None listed